Burkhard Jansen's most recent trade in DermTech Inc was a trade of 7,289 Stock Option (right to buy) done . Disclosure was reported to the exchange on March 29, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| DermTech Inc | Burkhard Jansen | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2021 | 7,289 | 7,289 | - | - | Stock Option (right to buy) | |
| DermTech Inc | Burkhard Jansen | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2021 | 4,897 | 84,991 (0%) | 0% | 0 | Common Stock | |
| DermTech Inc | Burkhard Jansen | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.94 per share. | 26 Jan 2021 | 5,000 | 79,037 (0%) | 0% | 6.9 | 34,700 | Common Stock |
| DermTech Inc | Burkhard Jansen | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jan 2021 | 5,000 | 16,244 | - | - | Stock Option (right to buy) | |
| DermTech Inc | Burkhard Jansen | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 12.41 per share. | 14 Dec 2020 | 5,000 | 79,037 (0%) | 0% | 12.4 | 62,050 | Common Stock |
| DermTech Inc | Burkhard Jansen | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 12.20 per share. | 11 Dec 2020 | 5,000 | 74,037 (0%) | 0% | 12.2 | 61,000 | Common Stock |